The world of science and medicine is based on a process of continuous research and development. Each discovery helps us enhance our understanding of ourselves and the environment leading to better and more accurate medical practices.
Genes and genomics is one such field of study that saw a breakthrough in 2003 and has been improving medical science ever since.
The Human Genome Project
It all began on October 1, 1990, with the commencement of the Human Genome Project. One of the greatest exploratory efforts in history, the HGP was an internal journey of discovery conducted by an international team of researchers who sought to sequence and map the complete genome of members of our species, Homo sapiens. The Human Genome Project allowed humanity to read nature’s entire genetic blueprint for creating a human being for the first time in April 2003.
A relatively new field in the world of science, genomics refers to the study of a person’s entire genome, including how their genes interact with one another and their environment. Genes are DNA regions that encode polypeptide chains or proteins, and the study of heredity and the diversity in inherited traits is known as genetics.
The landscape of research and clinical medicine was completely altered with the release of the human genome draught sequence. The vision of creating more personalized healthcare and tailored medicines was made possible by this genomic map. The era of “big data” was ushered in biomedical research, merging science, technology, and mathematics (the “s,” “t,” and “m” of “STEM”).
The two fundamental concepts in biology are that phenotypes emerge from changes in the genome and that all health and disease have a molecular basis based on the DNA “blueprint.” Thus, it may be argued that genomics has become a central discipline of medicine.
The global Gut Microbiome Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the gut microbiome market include Viome, Carbiotix, Ixcela, Inc., Novome Biotechnologies, Kintai Therapeutics, ProDigest, Caelus Health, LNC Therapeutics, AnimalBiome, and Assembly Biosciences.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Gut Microbiome Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/gut-microbiome-market/download-sampleMarket DynamicsThe high prevalence of homeostatic physiological disorders and inflammatory bowel diseases among the global population provides the main impetus for this market's growth.
Rising investments from government and private organizations in the research and development of novel therapeutics, health-conscious communities, and increased healthcare expenditure are the major factors for the steady growth of this market.
Lack of expertise and resources are some of the restraints on the market.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
